Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/all.15131 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The ICQ asthma algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.
Allergy
April 2022
Department of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles.
NPJ Prim Care Respir Med
January 2017
Discipline of Social & Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia.
REALISE Asia-an online questionnaire-based study of Asian asthma patients-identified five patient clusters defined in terms of their control status and attitude towards their asthma (categorised as: 'Well-adjusted and at least partly controlled'; 'In denial about symptoms'; 'Tolerating with poor control'; 'Adrift and poorly controlled'; 'Worried with multiple symptoms'). We developed consensus recommendations for tailoring management of these attitudinal-control clusters. An expert panel undertook a three-round electronic Delphi (e-Delphi): Round 1: panellists received descriptions of the attitudinal-control clusters and provided free text recommendations for their assessment and management.
View Article and Find Full Text PDFDevelopment of a brief questionnaire (ICQ-S) to monitor inhaled corticosteroid side-effects in clinical practice.
Allergy
March 2014
Clinical Management Group, Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.
Background: Side-effect concerns impede adherence with inhaled corticosteroids (ICS) and often underlie poor asthma control. We developed a brief version (ICQ-S) of the 57-item Inhaled Corticosteroids side-effect Questionnaire (ICQ) to facilitate side-effect monitoring in busy clinics.
Methods: Part 1: After completion by 482 patients with doctor-diagnosed asthma, each ICQ item underwent item reduction analysis.
Difference between patient-reported side effects of ciclesonide versus fluticasone propionate.
Respir Med
December 2010
Department of General Practice, University Medical Center Groningen, University of Groningen, Hanzeplein 1, Groningen, The Netherlands.
Rationale: Patient-reported outcomes provide new insights into the dynamics of asthma management. Further to asthma control and quality of life, self-reported side effects of treatment can be assessed with the validated Inhaled Corticosteroid Questionnaire (ICQ).
Objectives: To compare patient-reported side effects between the inhaled corticosteroids ciclesonide and fluticasone propionate.
A self-rating scale for patient-perceived side effects of inhaled corticosteroids.
Respir Res
October 2006
Department of General Practice and Primary Care, University of Aberdeen, UK.
Background: Patient-reported side effect questionnaires offer a simple method for the systematic measurement of drug-related side effects. In order to measure patients' inhaled corticosteroids (ICS) related side effect perceptions the 14-day retrospective Inhaled Corticosteroid Questionnaire (ICQ) was developed. In this research we aim to assess the construct validity and reliability of the ICQ and test its responsiveness to dose changes in adult asthma patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!